临床经验
Copyright ©The Author(s) 2006.
世界华人消化杂志. 2006-03-08; 14(7): 722-726
在线出版 2006-03-08. doi: 10.11569/wcjd.v14.i7.722
表1 红细胞ATP酶活性与离子含量 (mean±SD)
项目对照组(n = 36)实验组A(n = 52)实验组B(n = 36)P
ataPbtbPctcP
NKA21.48±3.8716.12±4.3318.12±3.575.92<0.0013.83<0.0012.28<0.05
CMA130.72±13.45108.80±14.40122.10±15.437.21<0.0012.53<0.024.14<0.005
RNa5.43±2.674.82±1.324.78±2.741.42>0.051.03>0.050.04>0.05
RK149.10±19.60141.20±12.38143.10±12.602.32<0.022.03<0.050.70>0.05
RCa0.83±0.110.79±0.130.82±0.161.48>0.050.31>0.050.97>0.05
RMg2.39±0.282.16±0.172.21±0.164.79<0.0013.33<0.0021.38>0.05
SNa140.10±3.80131.10±5.70138.80±4.128.25<0.0011.39>0.056.9<0.001
SK4.45±0.443.67±0.734.38±0.535.73<0.0010.61>0.055.00<0.001
SCa2.51±0.311.88±0.232.27±0.429.82<0.0011.75>0.055.57<0.001
SMg1.24±0.430.76±0.301.15±0.336.15<0.0011.00>0.055.73<0.001
表2 失代偿期患者不同Child分级组红细胞ATP酶活性与离子含量 (mean±SD)
项目B级(n = 29)C级(n = 23)TP
NKA17.42±3.4315.32±3.252.20<0.05
CMA114.28±12.04106.17±13.232.26<0.05
RNa5.05±1.084.82±1.240.70>0.05
RK143.43±10.22135.64±8.462.89<0.01
RCa0.82±0.100.79±0.180.76>0.05
RMg2.18±0.581.80±0.542.42<0.02
SNa132.12±4.22129.34±3.532.48<0.02
SK3.72±0.633.32±0.442.53<0.01
SCa1.97±0.171.83±0.222.59<0.02
SMg0.78±0.170.66±0.212.26<0.05
表3 肝性脑病患者与非肝性脑病患者细胞内外钙镁值(mean±SD)
项目非肝性脑病组(n = 41)肝性脑病组(n = 11)tP
NKA18.38±3.4715.12±3.052.81<0.01
CMA119.34±12.63104.67±14.433.29<0.01
RNa4.95±1.235.32±1.140.70>0.05
RK145.43±11.42134.96±10.362.73<0.01
RCa0.74±0.210.75±0.170.45>0.05
RMg2.31±0.541.82±0.622.57<0.02
SNa133.42±3.82129.36±3.353.19<0.01
SK3.84±0.713.28±0.422.43<0.05
SCa2.12±0.241.94±0.281.44>0.05
SMg0.87±0.250.62±0.232.89<0.01
表4 低血镁与非低血镁患者红细胞钠钾ATP酶、钙镁ATP酶 (mean±SD)
项目非低血镁组(n = 16)低血镁组(n = 36)tP
NKA19.04±3.2516.87±3.192.23<0.05
CMA120.13±13.27109.83±13.512.51<0.02

引文著录: 王方剑, 刘安立, 曹洁, 卢永宏, 赵青娥, 韩升祥, 蒙玲. 肝硬化红细胞钠钾ATP酶、钙镁ATP酶及钠钾钙镁改变. 世界华人消化杂志 2006; 14(7): 722-726